tenofovir alafenamide fumarate
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Various first‐line recommended antiretroviral therapy (ART) regimens have different drug‐drug interaction (DDI)/contraindication…
The frequent tenofovir disoproxil fumarate (TDF)‐related adverse drug reactions (ADRs) are nephrotoxicity and bone toxicity…
Scientific advances in the last three decades have helped transform HIV from a fatal disease into a chronic condition for many…
Abstract HIV treatment with tenofovir alafenamide fumarate (TAF) has decreased renal toxicity compared with tenofovir disoproxil…
Purpose of review In an era when virological efficacy approaches 100%, novel antiretroviral (ARV) therapies must deliver better…
In 2004, the US government began to utilize the Food and Drug Administration's (USFDA) tentative approval process (tFDA) as a…
Tenofovir alafenamide fumarate is a recently developed prodrug of tenofovir, a nucleotide analogue reverse transcriptase…
Approximately 84% of HIV-infected US residents on antiretroviral therapy currently receive some form of tenofovir disoproxil…
Individuals living with HIV thrive in the current era, having several potent, well tolerated options for initial combination…
Exploration of naturally occurring chemical structures for medicinal uses has received significant interest in drug discovery and…